FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100142107> ?p ?o ?g. }

• W3100142107 abstract "Background The standard treatment for high-risk neuroblastoma includes a combination immunotherapeutic approach consisting of IL-2, GM-CSF, and monoclonal antibodies directed against GD2, a disialoganglioside preferentially expressed in neuroblastoma and melanoma (1). We recently described an effective a preclinical in-situ vaccination strategy combining local radiation therapy (RT), IL-2-linked to anti-GD2 monoclonal antibody (intratumoral immunocytokine, IT-IC), checkpoint inhibition (anti-CTLA4), and drivers of innate immunity (anti-CD40 and CpG) (2). This strategy is effective in curing mice with immunologically-cold neuroblastoma. We sought to better characterize the anti-tumor mechanisms that mediate this effect. Methods Mice bearing GD2-expressing, immunologically-cold neuroblastoma tumors (9464D-GD2) were treated with 12Gy RT and combination immunotherapy (IT-IC, anti-CTLA-4, CpG, anti-CD40) over 12 days as previously described (2). Depletion of individual immune cell sets during treatment was achieved by depleting monoclonal antibodies and confirmed by flow cytometry. T-cell receptor deficient (TCR KO) mice were used to confirm findings in T-cell depletion experiments. 9464D-GD2 parental cells have low MHC-I expression; subclones with low and moderate MHC Class I expression were obtained by flow cytometry sorting and the impact of MHC class I expression on immune cell infiltrate and survival was assessed. Results The effectiveness of RT and combination immunotherapy was not significantly reduced by NK or T cell depletion, and TCR KO mice had similar tumor growth and survival to mice that underwent T-cell depletion. Moderate MHC class I expression did not slow tumor growth or improve survival in mice bearing 9464D-GD2 tumors (over those with low MHC-I) following treatment. Moderate MHC class I expression also did not alter individual immune cell subsets in treated tumors. Overall, increased infiltration of CD8 T-cells, CD4 T-cells, and depletion of T regulatory cells was observed in all treated tumors (p<0.05). Abstract 458 Figure 1 Effect of MHC class I expression on response to RT and combination immunotherapy (IT-IC, anti-CTLA4, anti-CD40, CpG). A) Increased MHC class I expression in 9464D-GD2 derived tumors did not alter tumor growth or survival following treatment. B) Increased MHC class I expression did not alter immune subsets following treatment of 9464D-GD tumors with radiation and combination immunotherapy. Increased numbers of CD8+ and CD4+ T-cells was observed with both moderate and absent MHC class I expression. T regulatory cells were also effectively depleted in both treated groups Conclusions Treatment with RT and combination immunotherapy (IT-IC, anti-CTLA4, anti-CD40, CpG) may act through mechanisms that are MHC class I, NK-cell and T-cell independent. Further investigation of the role of innate immunity and myeloid subsets in this scenario is warranted. Acknowledgements Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number T32 CA090217. References Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, et al. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma. New England Journal of Medicine 2010;363:1324–34 Voeller J, Erbe AK, Slowinski J, Rasmussen K, Carlson PM, Hoefges A, et al. Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition. Journal for Immunotherapy of Cancer 2019;7:13" @default.
• W3100142107 created "2020-11-23" @default.
• W3100142107 creator A5011569932 @default.
• W3100142107 creator A5012752519 @default.
• W3100142107 creator A5042234824 @default.
• W3100142107 creator A5069758017 @default.
• W3100142107 creator A5089532829 @default.
• W3100142107 date "2020-11-01" @default.
• W3100142107 modified "2023-09-26" @default.
• W3100142107 title "458 Antitumor mechanisms of local radiation and combination immunotherapy in an immunologically cold model of neuroblastoma" @default.
• W3100142107 cites W2621103187 @default.
• W3100142107 cites W2892033277 @default.
• W3100142107 doi "https://doi.org/10.1136/jitc-2020-sitc2020.0458" @default.
• W3100142107 hasPublicationYear "2020" @default.
• W3100142107 type Work @default.
• W3100142107 sameAs 3100142107 @default.
• W3100142107 citedByCount "0" @default.
• W3100142107 crossrefType "journal-article" @default.
• W3100142107 hasAuthorship W3100142107A5011569932 @default.
• W3100142107 hasAuthorship W3100142107A5012752519 @default.
• W3100142107 hasAuthorship W3100142107A5042234824 @default.
• W3100142107 hasAuthorship W3100142107A5069758017 @default.
• W3100142107 hasAuthorship W3100142107A5089532829 @default.
• W3100142107 hasConcept C159654299 @default.
• W3100142107 hasConcept C170627219 @default.
• W3100142107 hasConcept C203014093 @default.
• W3100142107 hasConcept C207936829 @default.
• W3100142107 hasConcept C2776090121 @default.
• W3100142107 hasConcept C2776715637 @default.
• W3100142107 hasConcept C2777701055 @default.
• W3100142107 hasConcept C502942594 @default.
• W3100142107 hasConcept C542903549 @default.
• W3100142107 hasConcept C54355233 @default.
• W3100142107 hasConcept C553184892 @default.
• W3100142107 hasConcept C71924100 @default.
• W3100142107 hasConcept C81885089 @default.
• W3100142107 hasConcept C86803240 @default.
• W3100142107 hasConcept C8891405 @default.
• W3100142107 hasConceptScore W3100142107C159654299 @default.
• W3100142107 hasConceptScore W3100142107C170627219 @default.
• W3100142107 hasConceptScore W3100142107C203014093 @default.
• W3100142107 hasConceptScore W3100142107C207936829 @default.
• W3100142107 hasConceptScore W3100142107C2776090121 @default.
• W3100142107 hasConceptScore W3100142107C2776715637 @default.
• W3100142107 hasConceptScore W3100142107C2777701055 @default.
• W3100142107 hasConceptScore W3100142107C502942594 @default.
• W3100142107 hasConceptScore W3100142107C542903549 @default.
• W3100142107 hasConceptScore W3100142107C54355233 @default.
• W3100142107 hasConceptScore W3100142107C553184892 @default.
• W3100142107 hasConceptScore W3100142107C71924100 @default.
• W3100142107 hasConceptScore W3100142107C81885089 @default.
• W3100142107 hasConceptScore W3100142107C86803240 @default.
• W3100142107 hasConceptScore W3100142107C8891405 @default.
• W3100142107 hasLocation W31001421071 @default.
• W3100142107 hasOpenAccess W3100142107 @default.
• W3100142107 hasPrimaryLocation W31001421071 @default.
• W3100142107 hasRelatedWork W11055546 @default.
• W3100142107 hasRelatedWork W2151330 @default.
• W3100142107 hasRelatedWork W2495403 @default.
• W3100142107 hasRelatedWork W2773312 @default.
• W3100142107 hasRelatedWork W50599 @default.
• W3100142107 hasRelatedWork W6021060 @default.
• W3100142107 hasRelatedWork W6705825 @default.
• W3100142107 hasRelatedWork W7677563 @default.
• W3100142107 hasRelatedWork W8453341 @default.
• W3100142107 hasRelatedWork W9749177 @default.
• W3100142107 isParatext "false" @default.
• W3100142107 isRetracted "false" @default.
• W3100142107 magId "3100142107" @default.
• W3100142107 workType "article" @default.